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Abstract
Background

Oral anticancer chemotherapy (OC) has been misperceived
as being safer than intravenous chemotherapy, leading
to its increased risk of improper handling and disposal.
This survey study assessed the knowledge, practices and
attitudes of pharmacists and patients regarding OC handling
and disposal, gaps in knowledge and barriers to patient
education.

Methods

Surveys were developed based on literature review and pilot
study validation results. Patients completed a 33-item paper
or electronic survey whereas pharmacists completed a 38item electronic survey. Descriptive statistics and Fisher’s
exact test computed using the R Project were used for
analyses.

Results

Pharmacist group (16/25, 62.5%) and patient group (14/29,
48.3%) believed that the oral route is safer than IV. Average
overall correct response rates for pharmacist and patient
groups were 78.3% and 61.9%, respectively. Significant
gaps in knowledge between groups were observed in three
sections (p < 0.05). Common barriers to providing patient
education were insufficient training (70.8%) and insufficient
time (50%).

Conclusion

Pharmacist and patient knowledge, awareness and practices
of OC safe handling and disposal are suboptimal. Areas
of knowledge gaps and barriers to patient education were
identified. Enhanced supports are needed to empower
pharmacists to assume an active role in patient education on
safe handling and disposal of OC.

Introduction
The use of oral anticancer chemotherapy (OC) drugs has
increased significantly since its introduction in the 1940s.
Approximately 25% of 400 novel chemotherapy agents in
development are oral agents that frequently require multiple
daily dosing regimens.1 With the burgeoning development of
novel OC, the number of newly approved OC drugs is expected
to increase multifold in the next few years. As reported in the
literature, the advantages of oral over parenteral chemotherapy
regimens can have a positive impact on the quality of life for

patients by avoiding venipuncture and other adverse events
associated with intravenous (IV) administration. It can provide
a greater sense of control over their cancer therapies and shift
drug administration from a traditional health care setting to a
more comfortable, self-managed setting, such as in patients’
homes.1,2 However, alongside these benefits, OC drugs carry
the same biohazardous properties that are associated with
carcinogenicity, reproductive toxicity, genotoxicity and organ
toxicity upon exposures.3 Improper handling and disposal
of these OC drugs not only increases the exposure risks in
the immediate home space, but also to the environment and
general population through air, surfaces, clothing, medical
equipment and patient excrements.4 A study by Fent et al.
showed that tablet trituration can cause fine dust formation
and local environmental contamination.5
Several studies have shown that patients, caregivers and
pharmacists generally misperceived OC to be less toxic
than their IV counterparts.6–10 In a survey that assessed
community pharmacists’ knowledge and attitudes toward
oral chemotherapy, 94.7% of pharmacist respondents
indicated that their pharmacy did not have separate
counting trays devoted to dispensing cytotoxic drugs.11 An
earlier joint survey conducted by the Hematology Oncology
Pharmacy Association (HOPA) and the International Society
of Pharmacy Practitioners (ISOPP) demonstrated that only
67.6% of member respondents considered that the handling
of OC drugs should require the same safety concerns as
parenteral formulations.12 A recent study also showed that
86% of the Veterans Affairs oncology patients perceived
OC drugs as being safe to handle without wearing gloves.10
Although the study was limited in the diversity of the study
population, the results are concerning.
These documented misperceptions involving both
pharmacists and patients can reasonably translate to less
guarded handling and disposal of OC drugs at home, thereby
increasing the risk of exposure to caregivers, visitors and
the public through personal contact and environmental
contaminations. The contamination of drinking water with
pharmaceuticals or medications has been reported in
environmental studies.13–15 An earlier study showed that more
than half of patients flushed unused or expired medication
into the toilet, and only 22.9% reported returning medication
to a pharmacy for disposal.16 Another report found 38%
of the patient respondents disposed of medications in the
toilet, sink or the trash.17 Based on the improper practices
of pharmacists and patients reported when handling OC
drugs and disposing of other medications,10,11,14,15 the
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potential environmental consequences from OC both in
the short and long term cannot be ignored. Although a few
published guidelines have addressed the safe handling and
disposal of OC drugs, they remain focused upon institutional
practice and are rarely adapted for the home setting.8,18 A
best practice model emphasizing outpatient care is needed
to improve awareness, education and safe practice around
OC handling and disposal by patients and caregivers.

The purpose of this study is to understand the current
knowledge, awareness, practices and attitudes of pharmacists
and patients on the handling and disposal of OC drugs. By
identifying potential gaps in knowledge among pharmacists
and patients and practice barriers of pharmacists to provide
patient education on this topic, we hope to optimize
educational efforts and to develop a regional best practice
model for safe handling and disposal of OC drugs (Figure 1).

Figure 1. Schematic of the Quality Improvement Process for the Proposed Best Practice Model

Methods
We conducted a questionnaire-based survey study, approved
by the Chapman University Institutional Review Board (IRB),
to evaluate the knowledge, awareness and practice of safe
handling and disposal of OC drugs among pharmacists and
patients. Two separate pharmacist- and patient-surveys were
developed based on literature, guidelines and professional
standards.1,8,12,19 Both surveys contained demographic items
and identical content items to assess participants’ knowledge,
awareness and attitudes on OC handling and disposal. The
pharmacist survey included supplemental items catered
toward practice on patient education. The identical content
items were analyzed for differences to determine the gaps
in knowledge between the pharmacists and patients. The
pharmacist survey was first pilot tested with 15 health care
providers, including nurses, oncologists and pharmacists.
The patient pilot survey was conducted with 11 patients
at a private oncology practice office located in Southern
California. The results of both pilot studies demonstrated
that the surveys were comprehensible, relevant and able
to be completed within a reasonable period of time. The
surveys with mild revisions were subsequently used in the
current studies. The pilot patient data were also included in
the final data analysis as the survey revisions did not alter the
evaluability of the responses.
The surveys (Appendixes 1 and 2) consisted of qualitative
(focused on demographics, practice and attitudes) and
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quantitative (focused on knowledge and practice) items.
There were 23 and 24 quantitative items in the pharmacist and
patient surveys, respectively. These items were categorized
into six sections; the number of items in each section were:
handling of OC (N = 4), OC storage in the home (N = 3),
physical manipulation of OC (N = 1 in pharmacist survey; N
= 2 in patient survey), handling of waste and clothing (N = 8),
disposal of OC (N = 3) and safety and exposure risk of OC (N
= 4). Selected content items (N = 11) were deemed as “critical
items,” in which 100% competency is desired based on their
significance in safe practice. Fifteen qualitative items were
included in the pharmacist survey to collect demographic
information (N = 4), patient education practice (N = 5), OC
dispensing practice (N = 5) and attitude toward OC safe
disposal (N = 1). Three of these qualitative items with openended responses were used to identify pharmacists’ roles
and the potential barriers in delivery of patient education
on OC handling and disposal, such as insufficient training
and insufficient time. The patient survey included seven
demographic and two medication history items.

Pharmacist Survey Study
The 38-item pharmacist survey was conducted in
collaboration with the California Society of Health-System
Pharmacists (CSHP). The Qualtrics survey link was
distributed by email via CSHP to its pharmacist members
across the state of California. Participants must have met the
following inclusion criteria: at least 18 years old, a registered
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pharmacist licensed in California and actively practicing in
an area where dispensing or handling oral chemotherapy
medications occurs.
Eligible participants reviewed a study information page
(Appendix 3) upon entering the survey site and provided
electronic consent prior to completing the questionnaire.
The participants had 60 days to complete the survey, and
reminder emails were sent periodically throughout the
timeframe to maximize the participation and response rates.
“Force response” of each item and “no backward navigation”
features in Qualtrics were used to set up the survey. Following
the data collection, the IP addresses of the participants were
stripped using the existing Qualtrics “anonymize response”
feature. No identifiable information was collected or stored
by CSHP nor the researchers.

Patient Survey Study
The IRB-approved 33-item patient statewide survey was
conducted at a private practice oncology office in Southern
California and a Walgreens pharmacy in Northern California.
Subjects who received care at these sites and met the
eligibility criteria were invited to participate in the study. The
inclusion criteria include: at least 18 years old, currently selfadministering OC or completed the OC regimen within the
last 12 months and must be able to complete the survey
in English independently or with aid from a caregiver. All
subjects signed an IRB-approved informed consent prior to
enrollment. Subjects were given the option to complete the
survey via hard copy or electronically in Qualtrics. Subjects
who preferred to complete the survey via a hard copy were
provided a survey package including a signed IRB-approved
informed consent and a hard copy of the survey to complete
during their visit. The completed surveys were collected
on-site. Subjects who preferred an electronic survey were
provided the electronic link by the investigator and a copy of
the signed informed consent. The subjects then completed
the survey either during their visits using an iPad provided by
the site or at home.

Data Handling and Analyses
Both pharmacist and patient data were deidentified, exported
and saved into secure encrypted folders that were accessible
only by the research team for statistical analysis. Survey data
were presented as numbers or percentages for categorical
variables. Critical items refer to the contents where 100%
patient/caregiver and pharmacist competencies are desired
were coded as “Yes” or “No.” Potential gaps of knowledge
were identified by examining the correct responses to the
survey items among and between study groups. If a statistical
significance of varied difference in the knowledge base was
observed between the two study groups, this indicated
a possible gap and/or barrier that may be preventing the
pharmacists from translating their knowledge to patients
through counseling and education.
All statistics were performed using The R Project software
for statistical computing version 3.6.2.20 Collaborative
descriptive analyses were used to assess the demographic
data collected from the two groups. To compare the responses
collected from the pharmacists and patients, a Fisher’s exact
test was computed using the R package “epitools.”21 Relative
risk ratio of pharmacists to patients and the 95% confidence
intervals were used to show the magnitude of the differences

between the two groups. Due to the use of multiple statistical
analyses, an adjustment to the p-values was added using the
method described by Benjamini and Hochberg.22 Two-sided
adjusted p-values of < 0.05 were considered significant.

Results
The surveys for pharmacists and patients were conducted
from September 2016 to September 2019 following IRB
approval. All study participants completed the survey online
or used a paper copy.

Subject Characteristics
Characteristics of study participants are summarized in
Table 1. Pharmacist participants (N = 25) were predominately
females (68%). Experience varied among different areas of
practice with a majority (60%) practicing for 10 or more years,
and only 3 out of 25 participants chose less than two years.
The majority of the pharmacists (68%) practiced in hospital
inpatient settings, followed by oncology specialty (2/25, 8%)
and ambulatory care (2/25, 8%). Only one participant worked
in the community pharmacy setting (4%). Furthermore, over
half of the pharmacist participants (52%) indicated they were
not specialty trained in oncology.
Patient participants (N = 29) were 62% female with the majority
aged 50 to 64 years old. More than half of the patients had a
college or higher education (N = 22, 76%). The most common
ethnic group was Caucasian (55%), followed by Asian/Asian
American (24%) and Latino/Hispanic or African American
(6.9%). Of note, 45% of patient participants reported vision
impairments and 14% reported hearing problems. The
majority of the patient participants had previously received
OC (72.4%) with 52.4% having received four or more OC
regimens.

Survey Results
Pharmacist survey: 24 out of 25 pharmacists (96%) completed
all the survey items (Table 1) and their correct response rates
to each item are outlined in Table 2. As shown in Figure 2,
the overall correct response rates of “handling of waste and
clothing” and “disposal of OC” were the lowest among all the
survey sections (70.8% and 72.2% respectively). “Handling
of waste and clothing” was the largest section containing
eight items; the most commonly missed items were: “Patient
double flushes toilet 48 hours after last chemotherapy”
(D5, 37.5% correct) and “Caregiver must double flush after
disposing of patient’s body waste” (D7, 45.8% correct). Both
items were critical items where a 100% correct response was
desired.
Other critical items with suboptimal responses revealed in the
pharmacist survey included washing hands (A2, A4), crushing
or splitting tablets (C1, C2), storage in original container (B1,
B2), wearing gloves when handling waste (D1), disposing of
unused OC in regular trash (E1) and skin exposure of OC (F2).
More than half of the pharmacists thought of oral anticancer
chemotherapy as safer compared to IV chemotherapy (F4,
N = 15, 62.5%).
For the items inquiring frequency in providing patient
education on handling oral chemotherapy drugs, 44% of the
pharmacists in the survey indicated an “as needed” basis
(11/25), 24% responded “at initiation of OC therapy” (6/25),
and 16% responded “never” (4/24). Only two participants
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Table 1. Pharmacist and Patient Characteristics
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Table 2. Survey responses of pharmacists (RPh) and patients (Pt) summarized by different sections.
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Figure 2. The overall correct response rates of pharmacists and patients in six assessed sections. N represents the
number of items in each section. The bars represent the overall average correct response rate (%) of each section, calculated
by [total correct responses/total responses received x 100%].

(8%) performed patient education during every appointment.
A similar pattern was observed in terms of the frequency of
performing patient education on OC disposal, with 36% “as
needed” and 24% on initial education only. More pharmacists
chose “never” in terms of educating patients on disposal (N =
7) compared to handling (N = 4).
When asked to identify barriers to patient education on OC,
the most frequently selected response by pharmacists was
insufficient training (70.8%) followed by insufficient time
(50%). Few pharmacists (8.3%) felt that it was not their
role/responsibility to provide patient education on OC. Two
participants chose “other” but did not provide a more detailed
explanation. One pharmacist chose “never heard about this.”
Patient survey: 25 out of the 29 (86%) patients completed all
the survey items. The patient group correct response rates
across all six sections ranged from 49.1% to 87.9%, with
a cumulative overall correct response rate of 61.9% (Table
2,). The lowest correct rate was in “handling of OC” (49.1%),
followed by the “safety and exposure risk of OC” section
(54.3%). The patient group achieved the highest correct rate
in the “physical manipulation of OC” section (87.9%).
As noted in Table 2, the patient group did not achieve a 100%
correct response rate in any of the critical items. Correct
response rates below 80% were observed in six out of the
14 critical items, including: proper hand-washing habits for
patients (A2, 55.2%) and caregivers (A4, 79.3%); bathroom
cross-contamination avoidance practice for patients (D5,
44.8%) and caregivers (D7, 62.1%); and exposure risks via
dermatologic route (F2, 58.6%) or unintentional ingestion (F3,
51.7%). In addition, almost half of the patient participants
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believed that “oral anticancer chemotherapy is safer than IV
chemotherapy” (F4, 48.3%).

Comparative Data Between the Two
Study Groups
Figure 2 illustrates the overall correct response rates in each
of the six sections of the quantitative items for each study
group. The pharmacist group consistently scored better than
the patient group in five of the six sections. Although the
patient group scored marginally higher than the pharmacist
group in the “physical manipulation of OC” section, both
groups scored over 80%.
We further analyzed the responses of each item between
pharmacists and patients as summarized in Table 2. Risk
ratios with 95% confidence intervals were computed to show
the magnitude of the differences along with a Fisher’s exact
test to determine statistical significance. There were six items
where pharmacists’ correct response rates were significantly
higher compared to patients. These items were distributed
in three sections: handling of OC, handling of waste and
clothing and safety and exposure risk of OC. Pharmacists
achieved 100% correct response rates in two items (“wash
hands when handling sheets or clothing” and “individuals
can be exposed by unintentional digestion”) compared to
75.9% (p = 0.04948) and 51.7% (p = 0.000758) in patients,
respectively. In terms of patients washing their hands (A2),
96% pharmacists chose “Yes” and only 55.1% of patients
think it is necessary (p = 0.0047). Other significant disparities
observed between pharmacists and patients include
“caregivers wearing gloves” (A3, p = 0.0005), “wearing
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Figure 3. Comparison of the survey responses between pharmacist and patient groups visualized using a balloon plot.
The value of the correct scores were represented by circle color and size. A bigger size with lighter color shows a higher correct
percentage (%).

gloves when handling sheets or clothing” (D2, p = 0.0001)
and “exposure risk of OC by skin contact” (F2, p = 0.049).
Similar notable insufficiencies of knowledge on OC identified
in both pharmacist and patient participants were in the areas
of “handling of waste and clothing” (D5-D8), “disposal of
empty containers in regular trash” (E3) and “patients wearing
gloves” (A1) as illustrated in Figure 3.

Discussion
With the increased use of OC, safe handling and disposal
of hazardous drugs need to be established and applied. In
examining the existing guidelines and regulations for health
care providers in proper handling and administration of
anticancer chemotherapy across the health care continuum in
the U.S. and internationally, it is apparent that there is limited
information available specifically on the safe handling and
disposal of OC. In 2013, ASCO and the Oncology Nursing
Society (ONS) published their joint updated standards for the
safe administration and management of oral chemotherapy.19

An international pharmacy panel also recommended
safe handling of oral chemotherapeutic agents in clinical
practices.8 Despite additional guidelines that had the intention
to address the area of oral chemotherapy,3,8,18,19,23–25 few of
them provided comprehensive information and guidance for
safe handling and disposal of hazardous medications in home
settings where OC is primarily being administered. In recent
years, increasing numbers of professional organizations,
health care networks and hospitals have developed provider
resources and/or patient education materials on OC.18,23,26,27
However, due to the scope of their membership and target
audience, these efforts may only benefit a small number of
users.
Pharmacists are regarded as the medication experts for
patient education and counseling due to their comprehensive
education in pharmacology.28 In our pilot survey, pharmacists
were highly regarded by other health care providers to play
an active role in patient education on proper handling and
disposal of OC. It has been well documented that pharmacist
interventions can improve outcome measurements in

Journal of Contemporary Pharmacy Practice | vol. 70, no. 2 | www.jcphp.com

29

outpatients with cancer aged > 50 years, leading to
significantly decreased adverse events and symptoms
related to cancer and improvements in patient satisfaction
and quality of life.29 Additional studies also reported a
significant improvement in knowledge-attitude-practice for
chemotherapy30 and improved awareness and knowledge
regarding adherence to laboratory parameter monitoring
following pharmacist interventions.31 Pharmacists play a vital
role in medication counseling and education, and should
be knowledgeable in order to keep patients and caregivers
well informed and to empower patients to make their own
health decisions concerning the safety of OC. Although the
surveyed pharmacists scored higher than patients in five out
of six sections of the quantitative items and achieved 100%
correct rate in two critical items, the overall responses from
pharmacists were suboptimal. The average correct response
rate in the quantitative items summarized in Table 2 was
78.3% (median = 87.5%, range = 37.5%-100%) with about
one-third of the items below 80% (7/24).
The need to improve patient knowledge and awareness is
also echoed by the results of the surveyed patients. The
average correct response rate in the quantitative items was
only 61.9% (median = 60.3%, range = 13.8%-96.6%). The
notable deficiencies of awareness on the safety and exposure
risk of OC at home provide the rationale for addressing this
knowledge gap. Optimizing the pharmacist counseling and
patient education may improve patient awareness of OC
safety.
The suboptimal performances of both study groups
substantiated the need for more education for pharmacists
and patients. The data from our study highlighted the
specific areas that deserve more attention in the design of
the educational model. A major concern identified by our
survey is that more than half of the pharmacist participants
(F4, 62.5%) and almost half of the patients (48.3%) believe
oral anticancer chemotherapy is safer than intravenous
chemotherapy. This misconception may have a negative
impact on the pharmacists’ attitudes, preventing them from
actively engaging in patients’ education and developing safe
practice habits. This is evidenced by the low frequency of
providing patient education from the pharmacist survey
response. Continual education among pharmacists and other
health care providers on these topics is greatly warranted to
improve their awareness and attitude, which may eventually
translate into the patients’ safe practices at home through
effective counseling. The patients and caregivers carry an
equally important role in safe practices when self-managing
their oral chemotherapy at home. Raising their knowledge
and awareness can improve outpatient OC care and safe
practice at home. Given the fast development in transitional
care management, more inpatient pharmacists are
performing structured discharge medication communication
and facilitation and timely post discharge follow-up. With
the increased prescribing of oral chemotherapy drugs and
their hazardous properties, it is imperative that pharmacists
in all practice settings must be prepared to provide clear
and concise patient education including safe handling and
disposal information. Motivational interviewing and teachback methods can be used to improve the medication
compliance and confirm the patient comprehension.
In examining the disparities of the response rates when
comparing the two study groups as seen in Figure 2, we
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identified the knowledge gaps between the pharmacists and
the patients. The sections that showed a high level of disparity
with the pharmacist group scoring above 80% are more likely
due to “insufficient time,” whereas the sections where both
groups did not score well may indicate “insufficient training.”
Recognizing that oncology training in pharmacy education
typically occurs post-graduation primarily for those who
enter specialty practice, a national comprehensive guideline
statement would be greatly beneficial in standardizing the
education and practice in the safe handling and disposal of
OC in the self-managed setting. Our data from the surveys
provided insight into the design of the educational program,
guideline development and resource support.
Aside from insufficient training and resource support, another
major barrier identified from our study was insufficient
patient counseling time, which is consistent with an earlier
study conducted in community pharmacies.32 Predeveloped
patient education information sheets on OC may allow
pharmacists to conduct patient education more effectively
with the time restriction and for patients to possess written
information as a reference when needed. In recent years,
more online informational resources have been developed
and available for reference and patient education, such as
the OralChemoEdSheets.com.27,33
Lastly, unsafe practice in the home setting can lead
to environmental exposure. In the last two decades,
water treatment centers had reported contamination
of groundwater and drinking water by medications.34–36
Although these publications did not specifically examine
hazardous agents, it is logical to expect the mechanisms
of environmental contamination to be similar irrespective
of the type of medications. Since 2012, an increasing
number of California counties have successfully passed and
implemented ordinances on safe medication disposal.37–41
These ordinances mandate the collection and safe disposal
of unneeded medications including hazardous agents to
prevent pollution of the environment. However, as shown
in an earlier study,9 patients rarely received instructions
from the dispensing pharmacy on the proper disposal of
hazardous drugs and their containers, and the medication
containers were not labelled accordingly. The California
Board of Pharmacy recognizes the impact of safe handling
and disposal of OC to the public health.42,43 On Jan. 30, 2019,
the board issued a policy statement to encourage voluntary
inclusion of a standardized hazardous drug symbol in the
OC prescription labels when appropriate, which serves as a
reminder for pharmacists to provide patient education and
for patients and caregivers to be mindful of special handling
and disposal of these medications.44
A major limitation of this study is the relatively small subject
size in both study groups. The number of expected pharmacist
participants was targeted at 500 based on a 20% response
rate of the estimated eligible members of CSHP. However,
the number of participants who completed the online
survey was low despite reminder efforts. Although our study
achieved statistically significant differences in the analyses,
a nationwide, large-scale study is warranted to capture more
diverse and larger subject populations. Furthermore, in this
study, we were not able to recruit caregivers, who play an
important role in providing cancer patient care at home and
can provide valuable insights for our research objectives. In
addition, the pharmacist participants were not well distributed
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with a majority from inpatient-based practices, which may be
attributed to the membership distribution of CSHP. Despite
this limitation, most of the outcome data observed from our
survey were consistent with the findings from an earlier study
conducted among community/retail pharmacists.11 Lastly,
both surveys used for this study did not go through the full
validation process and the internal consistencies have not
been evaluated.

Conclusion
Our survey data demonstrated that the knowledge,
awareness and practices of safe handling and disposal of
OC are suboptimal for both pharmacist and patient groups.
Education for both study populations is needed to enhance
the knowledge and safe practices of OC. Pharmacists should
establish active roles in patient education and counseling on
safe handling and disposal of OC. Comparing the responses
between pharmacists and the patients, significant gaps in
knowledge were observed in areas of OC handling, handling
of body waste and clothing and the exposure risk of OC.
Enhanced trainings and resources are needed to empower
pharmacists to assume an active role in patient education
and counseling on safe handling and disposal of OC.

Informed Consent and Patient
Details
I confirm all patient/personal identifiers have been removed
or disguised so the patient/person(s) described are not
identifiable and cannot be identified through the details of
the study.
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